Chelation Therapy of Atherosclerosis
- 1 December 1984
- journal article
- clinical trial
- Published by SAGE Publications in Drug Intelligence & Clinical Pharmacy
- Vol. 18 (12) , 1000-1003
- https://doi.org/10.1177/106002808401801221
Abstract
Chelation therapy with intravenous injections of edetate disodium is being promoted to the public as a nonsurgical means to treat coronary or other arterial atherosclerosis. The rationale for use, clinical efficacy, and safety are reviewed. Acceptable evidence supporting chelation therapy for atherosclerotic vascular disease is lacking.Keywords
This publication has 22 references indexed in Scilit:
- Reporting on Methods in Clinical TrialsNew England Journal of Medicine, 1982
- Chelation Therapy of Occlusive Arteriosclerosis in Diabetic PatientsAngiology, 1964
- The treatment of coronary artery disease with disodium EDTAThe American Journal of Cardiology, 1963
- HYPOGLYCÆMIA INDUCED BY DISODIUM ETHYLENEDIAMINE TETRA-ACETIC ACIDThe Lancet, 1961
- THE LONG TERM USE, SIDE EFFECTS, AND TOXICITY OF DISODIUM ETHYLENEDIAMINE TETRAACETIC ACID (EDTA)The Lancet Healthy Longevity, 1961
- Atherosclerosis, occlusive vascular disease and EDTAThe American Journal of Cardiology, 1960
- TREATMENT OF ANGINA PECTORIS WITH DISODIUM ETHYLENE DIAMINE TETRAACETIC ACIDThe Lancet Healthy Longevity, 1956
- Depression of cholesterol levels in human plasma following ethylenediamine tetracetate and hydralazineJournal of Chronic Diseases, 1955
- THE “IN VIVO” DISSOLUTION OF METASTATIC CALCIUM AN APPROACH TO ATHEROSCLEROSISThe Lancet Healthy Longevity, 1955
- Histogenesis of Coronary ArteriosclerosisCirculation, 1952